Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis. Howlett-Prieto Q, Feng X, Kramer JF, Kramer KJ, et al. Mult Scler 2021 Mar 30:13524585211003301. doi: 10.1177/13524585211003301.

Read + Share

Amedeo Smart

Independent Medical Education

Howlett-Prieto Q, Feng X, Kramer JF, Kramer KJ, et al. Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis. Mult Scler 2021 Mar 30:13524585211003301. doi: 10.1177/13524585211003301.
PMID: 33783270